Goflaxo Women Omega-3 Capsule — Vegan Flaxseed Oil with Evening Primrose Oil
₹809.00
100% vegan starch capsule combining cold-pressed flaxseed oil with evening primrose oil
Delivers omega-3 ALA + GLA (gamma-linolenic acid) — two fatty acids that target different but complementary aspects of women’s health
Primarily targets perimenstrual symptoms — breast tenderness, bloating, mood swings, cramping, and irritability
Also supports hormonal balance, skin health, and cardiovascular wellbeing
Free from fish, gelatin, and artificial additives
Manufactured at a USFDA-registered, WHO-GMP certified facility
- Helps relieve PMS symptoms — breast tenderness, bloating, irritability, and mood changes
- Reduces cramping and menstrual discomfort through anti-inflammatory prostaglandin regulation
- Supports hormonal balance — regulates the body’s sensitivity to prolactin across the menstrual cycle
- Reduces perimenopausal symptoms — hot flashes, night sweats, and mood disturbances
- Supports psychological wellbeing — reduces anxiety, mood swings, and sleep disturbances
- Improves skin hydration, elasticity, and barrier function — including hormonal acne
- Supports cardiovascular health — anti-inflammatory and anti-thrombotic effects
- May support bone health in perimenopausal women
- 100% vegan, plant-based, starch capsule — no fish, no gelatin, no animal derivatives
- Cold-pressed, non-oxidative extraction — no chemicals, no solvents
- Manufactured at a USFDA-registered, WHO-GMP certified facility
Inclusive of all taxes
Additional offers
Special offer: Coupon Applied! Use coupon GOFlaxo in cart.
Researched Omega-3 molecule derived from plant source and capsuled
- ALA (alpha-linolenic acid) — plant-based omega-3
- Supports cardiovascular health, reduces systemic inflammation, promotes cellular integrity
- GLA (gamma-linolenic acid) — specialised omega-6
- Directly relevant to the hormonal fluctuations of the menstrual cycle
- Modulates prostaglandin activity — reducing monthly symptoms at their biochemical root
- Work through complementary, non-competing pathways
- GLA converts to prostaglandin E1 (PGE1) — regulates hormonal sensitivity and reduces cycle-related inflammation
- Address what neither oil achieves alone
- GLA is found in very few dietary sources
- The body produces GLA from linoleic acid — but this conversion is impaired by hormonal changes, ageing, nutritional deficiencies, and heat-damaged dietary fats
- Women with PMS, irregular cycles, or hormonal imbalance are particularly prone to low GLA status
- Once absorbed: GLA → DGLA → Prostaglandin E1 (PGE1)
- PGE1 reduces the body's sensitivity to prolactin — the hormone directly linked to most PMS symptoms
- PGE1 also modulates the balance between pro-inflammatory and anti-inflammatory prostaglandins — reducing uterine cramping and menstrual pain
- This is the primary mechanism behind evening primrose oil's monthly benefits for women
- •Most PMS symptoms are linked to heightened sensitivity to prolactin: Breast tenderness · Bloating · Irritability · Mood swings · Headaches · Acne
- GLA → PGE1 directly dampens prolactin sensitivity — addressing the root hormonal trigger
- Clinical studies report reductions in breast swelling, irritability, bloating, and acne with EPO supplementation
- Benefits typically seen over 2–3 menstrual cycles of consistent use
- GLA's anti-inflammatory action also inhibits prostaglandin F2α — the prostaglandin responsible for uterine contractions and menstrual cramping
- One of the most common and distressing perimenstrual symptoms
- GLA reduces the inflammatory prostaglandins that drive cyclic breast pain
- EPO consistently noted as safe and reasonably well tolerated in clinical studies
- Particularly relevant for women seeking a non-pharmaceutical option
- Perimenstrual mood disturbances are driven by the same prolactin sensitivity that GLA addresses
- Triple-blind RCT (100 women) — 2 g EPO daily for 4 weeks:
- Menopause Rating Scale (MRS) score: dropped from 11 → 3 in EPO group
- Placebo group: dropped from 11 → ~10
- Clinically and statistically significant (Safdari et al., PMID: 34463069) Double-blind RCT (189 women) — 1,000 mg EPO daily for 8 weeks:
- Psychological symptom scores significantly better in EPO group vs placebo (p < 0.01)
- (Sharif SN & Darsareh F, PMID: 31738736)
- Benefits extend to premenopausal women experiencing cyclical mood and sleep disruption
- Perimenstrual skin flares — acne, oiliness, dryness — are driven by cyclical hormonal shifts
- GLA maintains the skin's lipid barrier and regulates moisture loss
- Associated with improved hydration, elasticity, and firmness
- Reduces redness, dryness, and inflammatory skin conditions triggered by hormonal fluctuation
- 12-week study: 87% of women reported skin looked and felt less dry
- RCT (56 women, aged 45–59, 6 weeks — 500 mg EPO twice daily):
- 39% improvement in hot flash frequency vs 32% placebo
- 42% improvement in severity vs 32% placebo (p < 0.05, statistically significant)
- Significantly better scores for social activities, relationships, and sexuality
- 2024 meta-analysis (450 women): mean reduction of 2.13 hot flashes per day in EPO group
- RCT (8 weeks, 1,000 mg EPO twice daily): significantly lower night sweat frequency and severity (p < 0.05)
- GLA reduces platelet aggregation and blood clot formation
- Supports healthy circulation and lowers cardiovascular risk
- 2024 BMC systematic review (44 trials): consistent evidence of GLA's role in modulating inflammatory and thrombotic pathways
- Combined with flaxseed oil's ALA — which reduces triglycerides and supports endothelial function — provides a dual approach to cardiovascular protection
- Perimenopausal bone loss accelerated by declining oestrogen and heightened inflammation
- Preliminary evidence: EPO + omega-3 + calcium may help slow bone loss
- Evidence remains limited — mechanistically plausible
- GLA's anti-inflammatory properties extend to the scalp
- Protects hair follicles from inflammatory damage
- Improves nutrient delivery to the scalp
- Supports hair density and reduces hormonally driven hair thinning
Marketed by Goflaxo Biosciences Pvt. Ltd. FSSAI
License No. 11524999000028
Email: care@goflaxo.com
Contact: 0712 4508513
Manufactured by Alder Biochem Pvt. Ltd. (WHO-GMP, ISO & NSF Certified Company)
FSSAI License No. 12622999000011
Email: care@alderbiochem.com
Contact: 0135-2698801

Fast & Safe
Delivery through trusted partner at your doorstep.

100% Authentic
Clinically researched ingredients manu- factured with approved and advanced facilities.

Easy and secure
Powered with secured multiple online payment options.

Make in India
Researched and manufactured proudly in India.





